Frequency Therapeutics Expands its Clinical Development Team, Adding Expertise in Inner Ear Physiology and Translational Science
It doesn't seem like a waste of time if they are still hiring.
And the open label trial shows some hope.
"At day 90 following dosing, thirty-four percent (34%) of...